Niknam Sasan, Shamshiri Mehrdad, Shahrzad Seyed Sahabaldin, Alipour Abbas, Rajabi Mohammad Bagher, Rajabi Mohammad Taher
Cornea Unit, Dr Khodadoust Eye Hospital, Shiraz, Iran.
Int J Ophthalmol. 2012;5(4):513-6. doi: 10.3980/j.issn.2222-3959.2012.04.21. Epub 2012 Aug 18.
To evaluate the effect of Intacs SK corneal ring segment implant for treatment of patients with moderate to severe keratoconus, who have clear central cornea and cannot tolerate contact lens.
In this prospective, non-comparative, interventional case series study performed in Dena Hospital, Shiraz, Iran, thirty-seven eyes of thirty-six patients with moderate to severe keratoconus, clear central cornea, and contact lens intolerance were enrolled and underwent Intacs SK corneal ring segment implantation. Preoperatively, uncorrected distance visual acuity (UCDVA), best-corrected distance visual acuity (BCDVA), central corneal thickness(CCT) and average keratometry (Av-K) were measured and compared with post-operative results at one week, one month, three months, and six months.
Mean preoperative UCDVA and BCDVA were (1.32±0.31)logMAR and (1.07±0.27)logMAR, respectively. Av-K was (52.13±0.39)D, and the CCT was (432±39.5)µm. Post-operative examinations showed a clinically significant improvement in both UCDVA and BCDVA (P<0.001). There was also a significant effect based on the time of assessment on both UCDVA and BCDVA and both parameters had a continuous improvement during the follow-up period. Three months after operation there was a statistical significant reduction of Av-K (P=0.0001), but there were no significant changes in CCT (P=0.149).
Intacs SK corneal ring segment implants seem to be a safe and effective treatment option for patients who have keratoconus, clear central cornea, and contact lens intolerance.
评估Intacs SK角膜环植入术对中度至重度圆锥角膜且中央角膜透明、不能耐受隐形眼镜患者的治疗效果。
在伊朗设拉子德娜医院进行的这项前瞻性、非对照、干预性病例系列研究中,纳入了36例中度至重度圆锥角膜、中央角膜透明且不耐受隐形眼镜患者的37只眼,并进行了Intacs SK角膜环植入术。术前测量未矫正远视力(UCDVA)、最佳矫正远视力(BCDVA)、中央角膜厚度(CCT)和平均角膜曲率(Av-K),并与术后1周、1个月、3个月和6个月的结果进行比较。
术前平均UCDVA和BCDVA分别为(1.32±0.31)logMAR和(1.07±0.27)logMAR。Av-K为(52.13±0.39)D,CCT为(432±39.5)µm。术后检查显示UCDVA和BCDVA均有临床显著改善(P<0.001)。基于评估时间,UCDVA和BCDVA也有显著影响,且两个参数在随访期间持续改善。术后3个月,Av-K有统计学显著降低(P=0.0001),但CCT无显著变化(P=0.149)。
对于患有圆锥角膜、中央角膜透明且不耐受隐形眼镜的患者,Intacs SK角膜环植入术似乎是一种安全有效的治疗选择。